Back to User profile » Dr Omar Abdel-Rahman
Papers published by Dr Omar Abdel-Rahman:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?
El Darsa H, El Sayed R, Abdel-Rahman O
Journal of Experimental Pharmacology 2020, 12:349-361
Published Date: 6 October 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I
Journal of Hepatocellular Carcinoma 2018, 5:109-119
Published Date: 19 November 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)
Rashad N, Abdel-Rahman O
Drug Design, Development and Therapy 2017, 11:947-954
Published Date: 24 March 2017
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/AlQ-TskaBPQ/1.jpg)
ElHalawani H, Abdel-Rahman O
Therapeutics and Clinical Risk Management 2015, 11:1123-1132
Published Date: 28 July 2015